Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 9, 2025SciEnggJ

Scaffold-free generation of non-contractile bioengineered cartilage to investigate the effects of inflammatory mediators on human chondrocytes

View Full Paper
Ask AI
Bookmark
Share

Authors

SRStephanie Richardson-SolorzanoDRDilpreet RayatASAlvin W. Su

Discussion

Loading...

Member takes

Overview

This research shows bioengineered cartilage responds to inflammatory mediators in chondrocytes, suggesting insights into osteoarthritis mechanisms.

Key Points

  • Non-contractile bioengineered cartilage maintains tissue integrity while investigating inflammatory impacts on chondrocytes.
  • IL-1β exposure alters mRNA levels associated with cartilage degradation and increases matrix metalloprotease activity.
  • Using TGF-β3 and actin inhibitors prevents tissue shrinkage, highlighting potential strategies for cartilage preservation.
  • This model may enable better understanding of human osteoarthritis progression compared to traditional animal studies.

Cite This Study

Richardson-Solorzano et al. (2025) studied this question.

synapsesocial.com/papers/68e70db790569dd607ee674fhttps://doi.org/10.54645/202518suphxq-22
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Engineered human osteoarthritic cartilage organoids2024 · 47 citations
  2. 2REPRODUCED CHONDRONS MAINTAIN CHONDROCYTE PHENOTYPE AND PROMOTE INFLAMMATORY RESPONSE IN A 3D OSTEOARTHRITIC CARTILAGE MODEL2025
  3. 3BIOMECHANICALLY LOADED 3D TISSUE-MIMETIC LAB-ON-A-CHIP MODELS FOR HUMAN INFLAMMATION AND FIBROSIS MODELLING2025
  4. 4Collagen and Alginate Hydrogels Support Chondrocytes Redifferentiation In Vitro without Supplementation of Exogenous Growth Factors2024 · 16 citations
  5. 5Engineering Allogeneic FE002-Cart Chondroprogenitor Spheroids for Large Knee Chondral Defects: Investigating Microenvironmental Cues for Functional Control, GMP Formulation, and Logistical Viability2026